Global Bacterial Enteric Disease Testing Market Growth (Status and Outlook) 2024-2030

Enteric diseases are infections that affect the gastrointestinal tract, which includes the stomach, small intestine, and large intestine. These diseases can be caused by various microorganisms such as bacteria, viruses, or parasites. Some common examples of enteric diseases include Clostridium difficile (C. difficile), campylobacteriosis, cholera, Escherichia coli (E. coli), Helicobacter pylori (H. pylori), salmonellosis, shigellosis, norovirus, rotavirus, amebiasis, cryptosporidiosis, and giardiasis.

The global Bacterial Enteric Disease Testing market size is projected to grow from US$ 3169 million in 2024 to US$ 3972 million in 2030; it is expected to grow at a CAGR of 3.8% from 2024 to 2030.

ReportPrime' newest research report, the “Bacterial Enteric Disease Testing Industry Forecast” looks at past sales and reviews total world Bacterial Enteric Disease Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacterial Enteric Disease Testing sales for 2023 through 2029. With Bacterial Enteric Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacterial Enteric Disease Testing industry.

This Insight Report provides a comprehensive analysis of the global Bacterial Enteric Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Bacterial Enteric Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacterial Enteric Disease Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacterial Enteric Disease Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacterial Enteric Disease Testing.

The surge in incidence rate of shigellosis, clostridium difficile (C. difficile), campylobacteriosis, cholera, Escherichia coli (E. coli), salmonellosis, and cholera, which may further cause severe diarrhea or death, drive the growth of the enteric disease testing market size.

For instance, according to research article “The burden of diarrhea, etiologies, and risk factors in India from 1990 to 2019: evidence from the global burden of disease study” published in 2022, in India, the total number of deaths of all ages was 632,344 in 2019 and the mortality rate is 45 per 100,000 population.

This report presents a comprehensive overview, market shares, and growth opportunities of Bacterial Enteric Disease Testing market by product type, application, key players and key regions and countries.

• Segmentation by Type:
  • Reagents and Consumables
  • Equipment
• Segmentation by Application:
  • Academic and Research Institutes
  • Hospital Laboratories
  • Pharmaceutical and Biotechnology Companies
• Market by Region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Becton Dickinson & Company
• Bio-Rad Laboratories, Inc
• Biomerieux SA
• Quest Diagnostics Inc
• Diasorin S.p.A.
• Meridian Bioscience Inc
• Abbott Laboratories
• Trinity Biotech
• Coris BioConcept
• Biomerica, Inc.
• Cepheid

Key Questions Addressed in this Report: